|
US4889861A
(en)
|
1982-12-21 |
1989-12-26 |
Ciba-Geigy Corp. |
Substituted imidazo[1,5-a]pyridine derivatives and other substituted bicyclic derivatives and their use as aromatase inhibitors
|
|
US4617307A
(en)
|
1984-06-20 |
1986-10-14 |
Ciba-Geigy Corporation |
Substituted imidazo[1,5-A]pyridine derivatives as aromatase inhibitors
|
|
US5120712A
(en)
|
1986-05-05 |
1992-06-09 |
The General Hospital Corporation |
Insulinotropic hormone
|
|
US5118666A
(en)
|
1986-05-05 |
1992-06-02 |
The General Hospital Corporation |
Insulinotropic hormone
|
|
US5114946A
(en)
|
1987-06-12 |
1992-05-19 |
American Cyanamid Company |
Transdermal delivery of pharmaceuticals
|
|
US4818541A
(en)
|
1987-08-19 |
1989-04-04 |
Schering Corporation |
Transdermal delivery of enantiomers of phenylpropanolamine
|
|
ES2113879T3
(en)
|
1990-01-24 |
1998-05-16 |
Douglas I Buckley |
GLP-1 ANALOGS USEFUL FOR THE TREATMENT OF DIABETES.
|
|
US5155100A
(en)
|
1991-05-01 |
1992-10-13 |
Ciba-Geigy Corporation |
Phosphono/biaryl substituted dipeptide derivatives
|
|
IL111785A0
(en)
|
1993-12-03 |
1995-01-24 |
Ferring Bv |
Dp-iv inhibitors and pharmaceutical compositions containing them
|
|
US5705483A
(en)
|
1993-12-09 |
1998-01-06 |
Eli Lilly And Company |
Glucagon-like insulinotropic peptides, compositions and methods
|
|
US5512549A
(en)
|
1994-10-18 |
1996-04-30 |
Eli Lilly And Company |
Glucagon-like insulinotropic peptide analogs, compositions, and methods of use
|
|
DE19616486C5
(en)
|
1996-04-25 |
2016-06-30 |
Royalty Pharma Collection Trust |
Method for lowering the blood glucose level in mammals
|
|
TW492957B
(en)
|
1996-11-07 |
2002-07-01 |
Novartis Ag |
N-substituted 2-cyanopyrrolidnes
|
|
CO5150173A1
(en)
|
1998-12-10 |
2002-04-29 |
Novartis Ag |
COMPOUNDS N- (REPLACED GLYCLE) -2-DIPEPTIDYL-IV PEPTIDASE INHIBITING CYANOPIRROLIDINS (DPP-IV) WHICH ARE EFFECTIVE IN THE TREATMENT OF CONDITIONS MEDIATED BY DPP-IV INHIBITION
|
|
CA2405895A1
(en)
|
2000-04-12 |
2001-10-18 |
Ronald Edward Steele |
Combination of organic compounds
|
|
TW200303742A
(en)
|
2001-11-21 |
2003-09-16 |
Novartis Ag |
Organic compounds
|
|
WO2003104200A1
(en)
|
2002-06-07 |
2003-12-18 |
Glaxo Group Limited |
N-mercaptoacyl phenyalanine derivatives, process for their preparation, and pharmaceutical compositions containing them
|
|
ATE335744T1
(en)
|
2002-08-07 |
2006-09-15 |
Novartis Pharma Gmbh |
ORGANIC COMPOUNDS AS AGENTS FOR TREATING ALDOSTERONE-RELATED CONDITIONS
|
|
PT1565463E
(en)
|
2002-11-18 |
2008-09-10 |
Novartis Ag |
Imidazo[1,5a] pyridine derivatives and methods for treating aldosterone mediated diseases
|
|
PT1638963E
(en)
|
2003-05-20 |
2009-11-18 |
Novartis Ag |
N-acyl nitrogen heterocycles as ligands of peroxisome proliferator-activated receptors
|
|
CA2568164A1
(en)
|
2004-05-28 |
2005-12-15 |
Speedel Experimenta Ag |
Heterocyclic compounds and their use as aldosterone synthase inhibitors
|
|
EP1765777A2
(en)
|
2004-05-28 |
2007-03-28 |
Speedel Experimenta AG |
Bicyclic, nitrogen-containing heterocycles as aromatase inhibitors
|
|
AR049388A1
(en)
|
2004-05-28 |
2006-07-26 |
Speedel Experimenta Ag |
HETEROCICLES AS INHIBITORS OF ALDOSTERONA SINTASA
|
|
AR049711A1
(en)
|
2004-07-09 |
2006-08-30 |
Speedel Experimenta Ag |
HETEROCICLIC COMPOUNDS CONDENSED AS INHIBITORS OF ALDOSTERONE SINTASA; PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM AND THEIR USE IN THE PREPARATION OF A MEDICINAL PRODUCT FOR THE TREATMENT OR PREVENTION OF DISEASES RELATED TO HYPERALDOSTERISM AND EXCESSIVE CORTISO RELEASE
|
|
TW200716634A
(en)
|
2005-05-31 |
2007-05-01 |
Speedel Experimenta Ag |
Heterocyclic spiro-compounds
|
|
TW200716105A
(en)
|
2005-05-31 |
2007-05-01 |
Speedel Experimenta Ag |
Imidazole compounds
|
|
TW200716636A
(en)
|
2005-05-31 |
2007-05-01 |
Speedel Experimenta Ag |
Heterocyclic spiro-compounds
|
|
GT200600381A
(en)
|
2005-08-25 |
2007-03-28 |
|
ORGANIC COMPOUNDS
|
|
TW200804378A
(en)
|
2005-12-09 |
2008-01-16 |
Speedel Experimenta Ag |
Organic compounds
|
|
DK2402317T3
(en)
|
2006-03-31 |
2013-10-07 |
Novartis Ag |
DGAT inhibitor
|
|
WO2007116908A1
(en)
|
2006-04-04 |
2007-10-18 |
Taiyo Nippon Sanso Corporation |
Method for separation of methane, methane separator, and methane utilization system
|
|
TW200808812A
(en)
|
2006-04-12 |
2008-02-16 |
Speedel Experimenta Ag |
Imidazo compounds
|
|
TW200808813A
(en)
|
2006-04-12 |
2008-02-16 |
Speedel Experimenta Ag |
Imidazo compounds
|
|
EP1886695A1
(en)
|
2006-06-27 |
2008-02-13 |
Speedel Experimenta AG |
Pharmaceutical combination of an aldosterone synthase inhibitor and a glucocorticoid receptor antagonist or a cortisol synthesis inhibitor or a corticotropin releasing factor antagonist
|
|
RU2009110442A
(en)
|
2006-08-25 |
2010-09-27 |
Новартис АГ (CH) |
CONDENSED IMIDAZOLE DERIVATIVES FOR TREATMENT OF DISORDERS MEDIATED BY ALDOSTEROSYNTHASE AND / OR 11-BETA-HYDROXYLASE, AND / OR AROMATASE
|
|
JP2010513482A
(en)
|
2006-12-18 |
2010-04-30 |
ノバルティス アーゲー |
Imidazoles as aldosterone synthase inhibitors
|
|
CN101578272A
(en)
|
2006-12-18 |
2009-11-11 |
诺瓦提斯公司 |
1-substituted imidazole derivatives and their use as aldosterone synthase inhibitors
|
|
EP2121652A1
(en)
|
2006-12-18 |
2009-11-25 |
Novartis AG |
4-imidazolyl-1,2,3,4-tetrahydroquinoline derivatives and their use as aldosterone/11-beta-hydroxylase inhibitors
|
|
RU2009139811A
(en)
|
2007-03-29 |
2011-05-10 |
Новартис АГ (CH) |
Heterocyclic compounds
|
|
TWI448284B
(en)
|
2007-04-24 |
2014-08-11 |
Theravance Inc |
Dual-acting antihypertensive agents
|
|
EP2200975A1
(en)
|
2007-09-07 |
2010-06-30 |
Theravance, Inc. |
Dual-acting antihypertensive agents
|
|
AR066169A1
(en)
|
2007-09-28 |
2009-07-29 |
Novartis Ag |
DERIVATIVES OF BENZO-IMIDAZOLES, USEFUL FOR DISORDERS ASSOCIATED WITH THE ACTIVITY OF DGAT
|
|
US7989484B2
(en)
|
2008-04-29 |
2011-08-02 |
Theravance, Inc. |
Dual-acting antihypertensive agents
|
|
AR072297A1
(en)
|
2008-06-27 |
2010-08-18 |
Novartis Ag |
DERIVATIVES OF INDOL-2-IL-PIRIDIN-3-ILO, PHARMACEUTICAL COMPOSITION THAT INCLUDES THEM AND ITS USE IN MEDICINES FOR THE TREATMENT OF DISEASES MEDIATED BY THE SYNTHESIS ALDOSTERONE.
|
|
US9085527B2
(en)
*
|
2008-07-08 |
2015-07-21 |
Catabasis Pharmaceuticals, Inc. |
Fatty acid acylated salicylates and their uses
|
|
MX2011004252A
(en)
*
|
2008-10-23 |
2012-01-27 |
Steba Biotech N V |
Rgd-containing peptidomimetics and uses thereof.
|
|
PE20120403A1
(en)
|
2009-05-15 |
2012-05-03 |
Novartis Ag |
ARYL-PYRIDINES AS INHIBITORS OF ALDOSTERONE SYNTHASE
|
|
EA201101672A1
(en)
|
2009-05-28 |
2012-06-29 |
Новартис Аг |
SUBSTITUTED DERIVATIVES OF AMINOISAL ACID AS NEPRILISIN INHIBITORS
|
|
AU2010251967B9
(en)
|
2009-05-28 |
2014-04-03 |
Novartis Ag |
Substituted aminopropionic derivatives as neprilysin inhibitors
|
|
JO2967B1
(en)
|
2009-11-20 |
2016-03-15 |
نوفارتس ايه جي |
Substituted carbamoylmethylamino acetic acid derivatives as novel NEP inhibitors
|
|
US8877815B2
(en)
|
2010-11-16 |
2014-11-04 |
Novartis Ag |
Substituted carbamoylcycloalkyl acetic acid derivatives as NEP
|
|
US8673974B2
(en)
|
2010-11-16 |
2014-03-18 |
Novartis Ag |
Substituted amino bisphenyl pentanoic acid derivatives as NEP inhibitors
|
|
CA2817368C
(en)
|
2010-12-15 |
2019-12-31 |
Theravance, Inc. |
Neprilysin inhibitors
|
|
ES2582640T3
(en)
|
2011-02-17 |
2016-09-14 |
Theravance Biopharma R&D Ip, Llc |
Substituted aminobutyric derivatives as neprilysin inhibitors
|
|
CA2835216A1
(en)
|
2011-05-31 |
2012-12-06 |
Theravance, Inc. |
Neprilysin inhibitors
|
|
CN103748070B
(en)
|
2011-05-31 |
2015-06-24 |
施万生物制药研发Ip有限责任公司 |
Neprilysin inhibitors
|
|
TWI560172B
(en)
|
2011-11-02 |
2016-12-01 |
Theravance Biopharma R&D Ip Llc |
Neprilysin inhibitors
|
|
PT2864292T
(en)
|
2012-06-08 |
2017-07-10 |
Theravance Biopharma R&D Ip Llc |
Neprilysin inhibitors
|
|
DE102012014480A1
(en)
|
2012-07-21 |
2014-01-23 |
Daimler Ag |
Construction of an interior decor
|
|
US9126956B2
(en)
|
2012-08-08 |
2015-09-08 |
Theravance Biopharma R&D Ip, Llc |
Neprilysin inhibitors
|
|
PE20151666A1
(en)
|
2013-02-14 |
2015-11-19 |
Novartis Ag |
SUBSTITUTE DERIVATIVES OF BISPHENYL BUTANOIC PHOSPHONE ACID AS INHIBITORS OF NEP
|
|
CA2902456A1
(en)
|
2013-03-05 |
2014-09-12 |
Theravance Biopharma R&D Ip, Llc |
Neprilysin inhibitors
|
|
EP2968318A4
(en)
*
|
2013-03-15 |
2016-12-14 |
Shifa Biomedical Corp |
Anti-pcsk9 compounds and methods for the treatment and/or prevention of cardiovascular diseases
|
|
RU2016135057A
(en)
|
2014-01-30 |
2018-03-12 |
ТЕРЕВАНС БАЙОФАРМА Ар энд Ди АйПи, ЭлЭлСи |
DERIVATIVES OF 5-BIPHENYL-4-HETEROARYL CARBONILAMINOPENTANIC ACID AS NEPRILISINE INHIBITORS
|
|
MX2016009760A
(en)
|
2014-01-30 |
2016-11-08 |
Theravance Biopharma R&D Ip Llc |
Neprilysin inhibitors.
|